Ryaltris (olopatadine hydrochloride and mometasone fluorate)
Defective Delivery System: The dip tube is clogged causing the spray not to work.
Yes — there is an active recall. 4 ongoing FDA recalls mention Mometasone (14 total). Check the affected lots below.
Most common reason: Packaging defect (5 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Mometasone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Defective Delivery System: The dip tube is clogged causing the spray not to work.
Defective Container
Defective Container
Defective Container
Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.
Defective Container
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
CGMP Deviaitons
GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.
Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.
CGMP Deviations: Market complaints related to "gritty texture".
Subpotent drug
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.